Boston Scientific Corporation BSX
NYSE
Recommendation
Dividend Power Score
Day's Range
$41.92$43.23
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.14B | 5.44B | 5.20B | 5.29B | 5.07B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.14B | 5.44B | 5.20B | 5.29B | 5.07B |
| Cost of Revenue | 1.72B | 1.61B | 1.60B | 1.61B | 1.54B |
| Gross Profit | 3.42B | 3.84B | 3.60B | 3.67B | 3.53B |
| SG&A Expenses | 1.68B | 1.80B | 1.78B | 1.83B | 1.74B |
| Depreciation & Amortization | 234.00M | 233.00M | 232.00M | 228.00M | 225.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.16B | 4.20B | 4.13B | 4.25B | 4.02B |
| Operating Income | 979.00M | 1.25B | 1.07B | 1.04B | 1.05B |
| Income Before Tax | 733.00M | 1.06B | 1.16B | 700.00M | 938.00M |
| Income Tax Expenses | 153.00M | 155.00M | -176.00M | 30.00M | 183.00M |
| Earnings from Continuing Operations | 580.00M | 905.00M | 1.34B | 670.00M | 755.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.00M | 2.00M | 2.00M | 2.00M | -- |
| Net Income | 582.00M | 907.00M | 1.34B | 672.00M | 755.00M |
| EBIT | 979.00M | 1.25B | 1.07B | 1.04B | 1.05B |
| EBITDA | 1.34B | 1.60B | 1.42B | 1.41B | 1.39B |
| EPS Basic | 0.40 | 0.62 | 0.90 | 0.45 | 0.51 |
| Normalized Basic EPS | 0.37 | 0.49 | 0.42 | 0.43 | 0.39 |
| EPS Diluted | 0.40 | 0.61 | 0.90 | 0.45 | 0.51 |
| Normalized Diluted EPS | 0.37 | 0.48 | 0.42 | 0.42 | 0.39 |
| Average Basic Shares Outstanding | 1.45B | 1.47B | 1.48B | 1.48B | 1.48B |
| Average Diluted Shares Outstanding | 1.45B | 1.47B | 1.50B | 1.50B | 1.50B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |